Evidence map›Paper›PMID 38813131›Full record

ArticleRSC advances2024

Synthesis and stability studies of bicyclo[6.1.0]nonyne scaffolds for automated solid-phase oligonucleotide synthesis.

Kristina Karalė, Martin Bollmark, Antanas Karalius, Mónica Lopes, Oswaldo Pérez, Roger Strömberg, Ulf Tedebark

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. A concise synthesis ofRSC advances · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kristina KaralėDepartment of Biosciences and Nutrition, Karolinska Institutet Neo 141 57 Huddinge Sweden kristina.karale@ri.se.ORCID https://orcid.org/0000-0002-4366-5833
Martin BollmarkRISE, Department Chemical Process and Pharmaceutical Development Forskargatan 18 SE-15136 Södertälje Sweden ulf.tedebark@ri.se.
Antanas KaraliusRISE, Department Chemical Process and Pharmaceutical Development Forskargatan 18 SE-15136 Södertälje Sweden ulf.tedebark@ri.se.
Mónica LopesRISE, Department Chemical Process and Pharmaceutical Development Forskargatan 18 SE-15136 Södertälje Sweden ulf.tedebark@ri.se.
Oswaldo PérezRISE, Department Chemical Process and Pharmaceutical Development Forskargatan 18 SE-15136 Södertälje Sweden ulf.tedebark@ri.se.
Roger StrömbergDepartment of Biosciences and Nutrition, Karolinska Institutet Neo 141 57 Huddinge Sweden kristina.karale@ri.se.ORCID https://orcid.org/0000-0002-7902-2688
Ulf TedebarkRISE, Department Chemical Process and Pharmaceutical Development Forskargatan 18 SE-15136 Södertälje Sweden ulf.tedebark@ri.se.ORCID https://orcid.org/0000-0002-9098-6410

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two novel bicyclo[6.1.0]nonyne (BCN) linker derivatives, which can be directly incorporated into oligonucleotide sequences during standard automated solid-phase synthesis, are reported. Stabilities of BCN-carbinol and two BCN-oligonucleotides are evaluated under acidic conditions. In addition, derivatized BCN linkers (non-acidic and acid treated) are evaluated for strain-promoted alkyne-azide cycloaddition (SPAAC).

Identifiers

PMID38813131
PMCPMC11134333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.